Gail V. Johnson - Publications

Cell Biology University of Alabama, Birmingham, Birmingham, AL, United States 
Cell Biology, Molecular Biology, Neuroscience Biology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Tapia-Rojas C, Cabezas-Opazo F, Deaton CA, Vergara EH, Johnson GVW, Quintanilla RA. It's all about tau. Progress in Neurobiology. PMID 30605723 DOI: 10.1016/j.pneurobio.2018.12.005  0.36
2016 Kim S, Choi KJ, Cho SJ, Yun SM, Jeon JP, Koh YH, Song J, Johnson GV, Jo C. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors. Scientific Reports. 6: 24933. PMID 27112200 DOI: 10.1038/srep24933  0.64
2015 Pallo SP, DiMaio J, Cook A, Nilsson B, Johnson GV. Mechanisms of tau and Aβ-induced excitotoxicity. Brain Research. PMID 26731336 DOI: 10.1016/J.Brainres.2015.12.048  0.64
2015 Chesser AS, Ganeshan V, Yang J, Johnson GV. Epigallocatechin-3-gallate enhances clearance of phosphorylated tau in primary neurons. Nutritional Neuroscience. PMID 26207957 DOI: 10.1179/1476830515Y.0000000038  0.64
2015 Pallo SP, Johnson GV. Tau facilitates Aβ-induced loss of mitochondrial membrane potential independent of cytosolic calcium fluxes in mouse cortical neurons. Neuroscience Letters. 597: 32-7. PMID 25888814 DOI: 10.1016/j.neulet.2015.04.021  0.64
2015 Zare-Shahabadi A, Masliah E, Johnson GV, Rezaei N. Autophagy in Alzheimer's disease. Reviews in the Neurosciences. PMID 25870960 DOI: 10.1515/Revneuro-2014-0076  0.64
2014 Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GV. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nature Communications. 5: 3496. PMID 24667209 DOI: 10.1038/Ncomms4496  0.36
2013 Quintanilla RA, Jin YN, von Bernhardi R, Johnson GV. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. Molecular Neurodegeneration. 8: 45. PMID 24330821 DOI: 10.1186/1750-1326-8-45  0.36
2012 Jin YN, Hwang WY, Jo C, Johnson GV. Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ. Plos One. 7: e30406. PMID 22276192 DOI: 10.1371/journal.pone.0030406  0.36
2010 Jin YN, Johnson GV. The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease. Journal of Bioenergetics and Biomembranes. 42: 199-205. PMID 20556492 DOI: 10.1007/s10863-010-9286-7  0.36
2009 Quintanilla RA, Johnson GV. Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Research Bulletin. 80: 242-7. PMID 19622387 DOI: 10.1016/j.brainresbull.2009.07.010  0.36
2009 Quintanilla RA, Matthews-Roberson TA, Dolan PJ, Johnson GV. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. The Journal of Biological Chemistry. 284: 18754-66. PMID 19389700 DOI: 10.1074/Jbc.M808908200  0.64
2008 Matthews-Roberson TA, Quintanilla RA, Ding H, Johnson GV. Immortalized cortical neurons expressing caspase-cleaved tau are sensitized to endoplasmic reticulum stress induced cell death. Brain Research. 1234: 206-12. PMID 18718455 DOI: 10.1016/J.Brainres.2008.07.111  0.36
2008 Ding H, Johnson GV. The last tangle of tau. Journal of Alzheimer's Disease : Jad. 14: 441-7. PMID 18688096 DOI: 10.3233/Jad-2008-14413  0.36
2008 Quintanilla RA, Jin YN, Fuenzalida K, Bronfman M, Johnson GV. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease. The Journal of Biological Chemistry. 283: 25628-37. PMID 18640979 DOI: 10.1074/jbc.M804291200  0.36
2008 Ding H, Johnson GV. New application of beta-galactosidase complementation to monitor tau self-association. Journal of Neurochemistry. 106: 1545-51. PMID 18498442 DOI: 10.1111/J.1471-4159.2008.05496.X  0.36
2007 Ruan Q, Quintanilla RA, Johnson GV. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin. Journal of Neurochemistry. 102: 25-36. PMID 17403029 DOI: 10.1111/j.1471-4159.2007.04491.x  0.36
Show low-probability matches.